Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 28 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-0.66 Insider Own2.89% Shs Outstand47.53M Perf Week2.82%
Market Cap1.62B Forward P/E- EPS next Y-0.58 Insider Trans-0.09% Shs Float46.21M Perf Month-0.70%
Income-30.44M PEG- EPS next Q-0.22 Inst Own99.82% Short Float5.06% Perf Quarter-19.14%
Sales399.25M P/S4.05 EPS this Y-10.26% Inst Trans-1.49% Short Ratio3.82 Perf Half Y-26.70%
Book/sh9.81 P/B3.46 EPS next Y20.74% ROA-5.08% Short Interest2.34M Perf Year-13.89%
Cash/sh2.88 P/C11.77 EPS next 5Y20.00% ROE-6.60% 52W Range29.67 - 59.61 Perf YTD-4.85%
Dividend Est.- P/FCF- EPS past 5Y-1.17% ROI-5.66% 52W High-43.03% Beta1.39
Dividend TTM- Quick Ratio2.66 Sales past 5Y15.61% Gross Margin74.86% 52W Low14.44% ATR (14)1.43
Dividend Ex-Date- Current Ratio3.57 EPS Y/Y TTM35.40% Oper. Margin-7.95% RSI (14)52.16 Volatility3.69% 4.15%
Employees1200 Debt/Eq0.16 Sales Y/Y TTM20.84% Profit Margin-7.62% Recom1.22 Target Price54.38
Option/ShortYes / Yes LT Debt/Eq0.15 EPS Q/Q-132.16% Payout- Rel Volume1.43 Prev Close34.19
Sales Surprise2.76% EPS Surprise6.58% Sales Q/Q21.03% EarningsFeb 15 AMC Avg Volume613.14K Price33.96
SMA202.11% SMA50-0.63% SMA200-19.24% Trades Volume878,716 Change-0.67%
Date Action Analyst Rating Change Price Target Change
Oct-23-23Initiated JMP Securities Mkt Outperform $60
Sep-29-23Initiated UBS Buy $56
Aug-05-21Downgrade Oppenheimer Outperform → Perform
Dec-18-20Reiterated Needham Buy $53 → $63
Nov-06-20Reiterated Needham Buy $63 → $53
Apr-07-20Initiated Oppenheimer Outperform $45
Feb-06-20Initiated BTIG Research Buy $42
Jan-24-20Reiterated Needham Buy $39 → $48
Aug-13-19Downgrade Northland Capital Outperform → Market Perform $30
Apr-12-19Initiated JP Morgan Overweight $37
Today 12:47AM
Feb-16-24 11:30AM
Feb-15-24 07:00PM
04:44PM Loading…
Feb-12-24 09:16AM
Jan-25-24 08:00AM
Jan-08-24 08:00AM
Jan-04-24 08:00AM
Dec-20-23 08:00AM
Nov-15-23 09:55AM
08:00AM Loading…
Nov-14-23 08:00AM
Nov-06-23 12:00PM
Nov-02-23 03:14PM
Nov-01-23 06:22PM
Oct-31-23 08:00AM
Oct-11-23 08:00AM
Sep-29-23 09:40AM
Sep-11-23 11:45AM
Sep-09-23 07:32PM
Jul-29-23 01:10AM
Jul-27-23 08:50AM
07:49AM Loading…
Jul-26-23 07:49AM
Jul-25-23 08:00PM
Jul-21-23 08:00AM
Jul-03-23 08:00AM
May-25-23 04:02AM
May-04-23 06:21AM
May-03-23 10:50AM
May-02-23 05:25PM
Apr-19-23 08:00AM
Apr-17-23 10:42AM
Apr-11-23 08:00AM
Apr-03-23 08:00AM
Apr-01-23 09:41PM
Mar-27-23 08:29AM
Mar-18-23 09:14AM
Feb-25-23 02:14PM
Feb-21-23 05:15PM
Feb-17-23 08:00AM
Jan-31-23 08:00AM
Jan-24-23 08:00AM
Jan-09-23 08:00AM
Dec-31-22 08:07AM
Dec-20-22 08:00AM
Dec-08-22 10:30AM
Dec-04-22 07:20AM
Nov-08-22 08:00AM
Nov-01-22 05:55PM
Oct-26-22 10:01AM
Oct-25-22 10:01AM
Oct-11-22 08:00AM
Oct-09-22 08:53AM
Sep-06-22 08:00AM
Aug-16-22 08:00AM
Aug-02-22 05:15PM
Jul-28-22 09:44AM
Jul-20-22 08:00AM
Jul-12-22 08:00AM
Jul-06-22 07:09PM
Jun-18-22 09:31AM
Jun-07-22 08:00AM
Jun-01-22 01:16PM
May-05-22 12:45PM
May-04-22 03:39PM
May-03-22 05:15PM
May-02-22 08:30AM
Apr-28-22 05:45PM
Apr-12-22 08:00AM
Apr-11-22 08:00AM
Apr-09-22 09:43AM
Feb-23-22 07:23AM
Feb-16-22 10:00AM
Feb-15-22 05:15PM
Feb-10-22 05:35PM
Feb-08-22 03:00PM
Feb-03-22 08:55AM
AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded in 1994 and is headquartered in Mason, OH.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WHITE ROBERT S.DirectorFeb 23Option Exercise15.9610,000159,60088,985Feb 27 09:00 AM
Dahlquist Karl S.Chief Legal OfficerNov 01Sale34.431,24842,96930,789Nov 03 08:40 AM
Dahlquist Karl S.Chief Legal OfficerJul 26Sale57.093,417195,07732,037Jul 28 08:39 AM
Prange KarenDirectorJun 08Sale47.8971334,14616,140Jun 12 08:59 AM
Dahlquist Karl S.Chief Legal OfficerJun 06Sale47.031,42266,87734,897Jun 07 08:43 AM
Yuen MaggieDirectorMay 26Sale47.044,313202,8844,682May 30 04:05 PM
Dahlquist Karl S.Chief Legal OfficerMay 01Sale44.834,417198,01436,319May 03 04:03 PM
Collar Mark ADirectorMar 13Option Exercise9.3010,00093,000100,871Mar 15 05:07 PM